actrims 2020 news network: opera i/ii trials on relapsing ms
Published 4 years ago • 385 plays • Length 2:15Download video MP4
Download video MP3
Similar videos
-
3:45
actrims 2020 news network: updated data from the clarity study
-
2:47
actrims 2020 news network: 6-year data with ocrelizumab
-
2:54
open-label extension: phase 3 opera i and ii trials in relapsing ms
-
4:23
opera i & ii trials show promise for two forms of multiple sclerosis
-
6:01
ocrelizumab for relapsing ms
-
![remyelination for multiple sclerosis [clemastine]](https://i.ytimg.com/vi/T6p5e2TcR9Q/mqdefault.jpg)
10:46
remyelination for multiple sclerosis [clemastine]
-
1:23:22
ms conversations now with dr. aaron boster, md
-
5:42
jerry & pam's story
-
3:09
le hua, md: considering age in multiple sclerosis treatment
-
19:31
multiple sclerosis research: actrims 2022 update with dr barry singer
-
8:37
actrims meeting shows signs of hope for progressive ms patients
-
39:02
report from actrims/ectrims part i
-
2:36
chimes: ocrelizumab in black/african american and hispanic/latino individuals with relapsing ms
-
1:38
serious mental illness & the value of adherence
-
2:36
patricia k. coyle, md: the me-too drugs in the ms pipeline
-
2:18
access to healthcare has never been so important
-
9:49
actrims forum 2021 - overview of day 2
-
19:10
optimal dose of ocrevus for multiple sclerosis
-
6:17
sinfonie no. 31 d-dur, kv 297 pariser sinfonie: ii. andantino grazioso
-
1:09
#meetopera: opera is open
-
50:00
lv cases
-
3:59
covid-19 and multiple sclerosis: how scientific research is proceeding to provide answers